Pharmacovigilance
Pharmacovigilance Department
Pharmacovigilance (FV) Department of VITEMA S.A. has the permanent objective of continuously monitoring the safety of medicines for which the company is the Marketing Authorization Holder (MAH). The specialists within this department collect safety information that arises from the medical practice use of VITEMA products, information whose subsequent scientific analysis provides data on possible changes in the benefit/risk balance of the medicines.
Furthermore, the company has ensured that it can take all necessary measures to minimize risks when needed, thereby assuming responsibility for the medicines it has launched on the market.
What is an adverse reaction?
An adverse reaction is defined as “a harmful and undesirable response caused by a medicine” and may or may not be mentioned in the medicine’s leaflet.
If you experience any adverse reactions, contact your doctor or pharmacist. These include any adverse reactions mentioned or not mentioned in the medicine’s leaflet.
Furthermore, the company has ensured that it can take all necessary measures to minimize risks when needed, thereby assuming responsibility for the medicines it has launched on the market.
Investments in Technology
Countries Exports
Commercial Units
Automation
Report an adverse reaction
To report a suspected adverse reaction to a VITEMA medicine, you can directly contact the Pharmacovigilance Service:
Download Our Brochure
Contact Our Team
Subscribe Now
Main Menu
Vitema
Manufacturing
Copyright © 2024 Vitema Pharmaceuticals
